Andrew J. Schwab - Oct 15, 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Director, 10%+ Owner
Signature
By: /s/ Thomas Danielski, Attorney-in-Fact
Stock symbol
CAMP
Transactions as of
Oct 15, 2024
Transactions value $
$9,999,990
Form type
4
Date filed
10/15/2024, 05:48 PM
Previous filing
Oct 10, 2024
Next filing
Oct 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAMP Common Stock Conversion of derivative security +1.34M 1.34M Oct 15, 2024 See Footnote F1, F2
transaction CAMP Common Stock Conversion of derivative security +378K +28.29% 1.72M Oct 15, 2024 See Footnote F2, F3
transaction CAMP Common Stock Conversion of derivative security +303K 303K Oct 15, 2024 See Footnote F3, F4
transaction CAMP Common Stock Purchase $10M +909K +52.98% $11.00 2.63M Oct 15, 2024 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Series A Prime Preferred Stock Conversion of derivative security -15M -100% 0 Oct 15, 2024 Common Stock 1.34M See Footnote F1, F2
transaction CAMP Series B Preferred Stock Conversion of derivative security -4.24M -100% 0 Oct 15, 2024 Common Stock 378K See Footnote F2, F3
transaction CAMP Series B Preferred Stock Conversion of derivative security -3.4M -100% 0 Oct 15, 2024 Common Stock 303K See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.
F2 The reported securities are held directly by 5AM Ventures VI, L.P. ("5AM Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of 5AM Ventures VI. The Reporting Person is a managing member of Partners VI and may be deemed to share voting and investment power over the shares held by 5AM Ventures VI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F3 On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
F4 The reported securities are held by 5AM Opportunities II, L.P. ("5AM Opportunities"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of 5AM Opportunities. The Reporting Person is a managing member of Opportunities II GP and may be deemed to share voting and investment power over the shares held by 5AM Opportunities. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.